“The high CD4/CD8 ratio and suppressed NK cell activity were improved by methyl-B12 treatment.” The Japanese researchers state: “We conclude that vitamin B12 acts as an immunomodulator for cellular immunity.”11 B12 was used successfully in the treatment bed canopies of ige-mediated skin disorders. the german researchers conclude that b12 (cobalamin) when applied to the skin one or more times per day exhibited “...excellent results in topical treatment of skin disorders wrap bed and in particular of inflammatory and hyperproliferative skin ailments and/or cutaneous manifestations of illness which are immunologic in origin, e.g. psoriasis, atopic dermatitis, contact dermatitis, and other eczematous dermatitises...”12 click here for allergy medication online.

a recent study in japan indicates that b12 treatment helps in the growth and division of certain immune system cells.11 these cells function to prevent the immune system from over-reacting to allergens such as animals, mold, dust, and pollen. they are called suppressor cells or cd8+ lymphocytes. they “put the brakes on the immune system”. this medicationtm is a 21-day treatment of b12 lozenges sucked on twice daily. this medicationtm may help patients with hay fever by providing the patient’s suppressor cells with the sustained and elevated blood b12 level they need to grow and divide. it appears that by helping the immune system to become what it is genetically capable of becoming, this medicationtm turns at least some allergic people into non-allergic or moderately-allergic people.

in 1992 in el paso, tx a randomized, double-blind, placebo controlled study of subjects (n=130) with allergic rhinitis in 1992-1993 was conducted. the average ige level of the placebo treated subjects remained essentially flat, while the average wholesale bed ige level for active treated subjects was reduced significantly from baseline to day 30.7 in 1993 in el bed paso, tx, valid subjects (n=66) returned a second set of symptom diaries which they had completed for days 365 to 395 (the same period, one year after the first set of symptom diaries). the active group had mean symptom scores showing statistically significant decreases from 1992 to 1993. the placebo group had increased symptoms in 1993. (the relevant pollen counts at the study site in 1993 were much higher than in 1992, leading to expectation of higher symptoms.)7

©2003 www.mattress-air-beds.com All rights reserved.